Abstract:Dietary n-3 polyunsaturated fatty acid (PUFA) exerts anti-inflammatory and immunoregulatory effects via downregulation of the innate and adaptive immune responses. However, the effect of dietary n-3 PUFA on experimental Crohn's Disease (CD) in rats and the underlying mechanisms are unclear. The present study aimed to investigate the effects of n-3 PUFA on CD induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS) in rats, and to determine the underlying mechanisms, including the peroxisome proliferator-activated receptor (PPAR)-gamma and nuclear factor of activated T-cells (NFAT) pathway. Sprague-Dawley rats (n=90) were randomly assigned to the following groups: Control (intragastric distilled water); PUFA control (intragastric n-3 PUFA, 20 mg/kg/day); trans-fatty acid (TFA) control (intragastric TFA, 13 mg/kg/day); model (intragastric distilled water + TNBS); PUFA model (intragastric n-3 PUFA, 20 mg/kg/day + TNBS); and TFA model (intragastric TFA, 13 mg/kg/day + TNBS). The disease activity index (DAI), colon macroscopic damage index (CMDI) and tissue damage index (TDI) were evaluated. The expression of PPAR-gamma, NFAT, interleukin (IL)-4 and IL-2 mRNA in colonic tissues was determined by reverse transcriptionquan-titative polymerase chain reaction (RT-qPCR), and the serum levels of IL-6, IL-12, tumor necrosis factor-a and interferon-gamma were measured by ELISA. The results demonstrated that dietary n-3 PUFA markedly attenuated colonic inflammation compared with the model group, as indicated by reduced DAI, CMDI and TDI scores, amelioration in pathological evaluation and improvements in localized mucosal inflammation, as indicated by the levels of cytokines associated with local mucosal immunity. Treatment with n-3 PUFA increased the gene expression of PPAR-gamma in TNBS-treated rats, and reduced the expression of NFAT, which ultimately reduced the release of IL-4 and IL-2 detected by RT-qPCR. A TFA-enriched diet was observed to increase DAI and TDI scores, aggravate pathological inflammation with epithelioid granulomas and enhance the release of proinflammatory cytokines, compared with the model group. In conclusion, the present study demonstrated that dietary n-3 PUFA may attenuate experimental CD induced by TNBS in rats by regulating the expression and activity of the PPAR-gamma/NFAT signaling pathway. These results provide a promising potential therapeutic method for the treatment of CD.

DHA Protects Against Experimental Colitis in IL-10-deficient Mice Associated with the Modulation of Intestinal Epithelial Barrier Function

Docosahexaenoic Acid Attenuated Experimental Chronic Colitis in Interleukin 10–Deficient Mice by Enhancing Autophagy Through Inhibition of the mTOR Pathway

Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis

Orally Administered DHA Enriched Phospholipids and DHA Enriched Triglyceride Relief Oxidative Stress, Improve Intestinal Barrier, Modulate Inflammatory Cytokine and Gut Microbiota, and Meliorate Inflammatory Responses in the Brain in DSS-Induced Colitis in Mice.

Orally Administered Dha-Enriched Phospholipids And Dha-Enriched Triglyceride Relieve Oxidative Stress, Improve Intestinal Barrier, Modulate Inflammatory Cytokine And Gut Microbiota, And Meliorate Inflammatory Responses In The Brain In Dextran Sodium Sulfate Induced Colitis In Mice

Algal Oil Rich in n-3 PUFA Alleviates DSS-Induced Colitis via Regulation of Gut Microbiota and Restoration of Intestinal Barrier

Trans-10-Hydroxy-2-Decenoic Acid Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice Via Regulating the Inflammasome-Mediated Pyroptotic Pathway and Enhancing Colonic Barrier Function

Docosahexaenoic acid (DHA) promotes recovery from postoperative ileus and the repair of the injured intestinal barrier through mast cell-nerve crosstalk

Isosteviol Attenuates DSS-induced Colitis by Maintaining Intestinal Barrier Function Through PDK1/AKT/NF-κB Signaling Pathway

Dihydroartemisinin Modulates Enteric Glial Cell Heterogeneity to Alleviate Colitis

IL-10 Modulates DSS-induced Colitis Through a Macrophage–ros–no Axis

Protective Effects of High-Fat Diet against Murine Colitis in Association with Leptin Signaling and Gut Microbiome

P-Hydroxybenzoic Acid Ameliorates Colitis by Improving the Mucosal Barrier in a Gut Microbiota-Dependent Manner.

Heme Oxygenase-1 Ameliorates Dextran Sulfate Sodium-induced Acute Murine Colitis by Regulating Th17/Treg Cell Balance

DHA-Enriched Phospholipids and EPA-Enriched Phospholipids Alleviate Lipopolysaccharide-Induced Intestinal Barrier Injury in Mice <i>via</i> a Sirtuin 1-Dependent Mechanism

Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.

Dietary N-3 Polyunsaturated Fatty Acids Ameliorate Crohn's Disease in Rats by Modulating the Expression of PPAR-gamma/NFAT

MD-1 Deficiency Attenuates Dextran Sodium Sulfate (Dss)-Induced Colitis Through Modulating the Function of Colonic Lamina Propria Dendritic Cells

Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling

EPA and DHA differentially coordinate the crosstalk between host and gut microbiota and block DSS-induced colitis in mice by a reinforced colonic mucus barrier

Hydroxyproline Attenuates Dextran Sulfate Sodium‐Induced Colitis in Mice: Involvment of the NF‐κB Signaling and Oxidative Stress